The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils

NeuroReport

Volumn 9, Issue 6, 1998, Pages 985-988

  Henrich Noack, Petra ^a   Hatton, Christopher D ^a   Reymann, Klaus G ^a  

^a Research Institute Applied Neurosciences   (Germany)

Author keywords

(S) 4C3HPG; Cerebral ischaemia; Gerbil; Hippocampus; mGlu receptors; Neuroprotection

Indexed keywords

4 CARBOXY 3 HYDROXYPHENYLGLYCINE; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; LIGAND; METABOTROPIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GERBIL; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0032550097     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199804200-00006     Document Type: Article

References (27)

1. Araki T, Kato H and Kogure K. Acta Neurol Scand 80, 548-553 (1989).
2. Rothman SM and Olney JW. Ann Neurol 19, 105-111 (1986).
3. Conn PJ and Pin JP. Annu Rev Pharmacol Toxicol 37, 205-237 (1997).
4. Choi DW. Science 258, 241-243 (1992).
5. Bruno V, Sureda FX, Storto M et al. J Neurosci 17, 1891-1897 (1997).
6. Opitz T, Richter P, Carter AJ et al. Neurosci 68, 989-1001 (1995).
7. Brabet I, Mary S, Bockaert J and Pin JP. Neuropharmacology 34, 895-903 (1995).
8. Kingston AE, Burnett JP, Mayne NG and Lodge D. Neuropharmacology 34, 887-894 (1995).
9. Watkins J and Collingridge G. Trends Pharmacol Sci 15, 333-342 (1994).
10. Henrich-Noack P and Reymann KG. Naunyn-Schmied Arch Pharm 355 suppl., 92 (1997).
11. Buisson A and Choi DW. Neuropharmacology 34, 1081-1087 (1995).
12. Orlando LR, Standaert DG, Penney JB and Young AB. Neurosci Lett 202, 109-112 (1995).
13. Thomsen C, Klitgaard H, Sheardown M et al. J Neurochem 62, 2492-2495 (1994).
14. Siesjö BK and Bengtsson F. J Cerebr Blood Flow Metab 9, 127-140 (1989).
15. Bruno V, Copani A, Knöpfel K et al. Neuropharmacology 34, 1089-1098 (1995).
16. Mukhin A, Fan L and Faden AI. J Neurosci 16, 6012-6020 (1996).
17. Ferraguti F, Pietra C, Valerio E et al. Neuroscience 79, 1-5 (1997).
18. Mannaioni G, Jager T, Schroder UH et al. Neuropharmacology 35A, 20-77 (1996).
19. Pellegrini-Giampietro D, Torregrossa S and Moroni F. Br J Pharm 118, 1025-1073 (1996).
20. Manzoni OJ, Castiilo PE and Nicoll RA. Neuropharmacology 34, 965-971 (1995).
21. Onodera H, Sato G and Kogure K. Neurosci Lett 68, 169-174 (1986).
22. Wieloch T, Lindvall O, Blomqvist P and Gage FH. Neurol Res 7, 24-26 (1985).
23. Winder DG, Ritch PS, Gereau RW IV and Conn PJ. J Physiol 494.3, 743-755 (1996).
24. Henrich-Noack P and Reymann KG. Abstract book of the XXXIII International Congress of Physiological Sciences, June 30-July 5 in St. Petersburg (1997).
25. Maginn M, Caldwell M, Kelly JP and Leonhard BE. Eur J Pharmacol 28, 259-262 (1995).
26. Schoepp DD and Johnson BG. Neurochem Int 22, 277-283 (1993).
27. Scanziani M, Salin PA, Vogt KE et al. Nature 386, 630-634 (1997).